|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| C08G 65/08 | (2006.01) | ||
| A61P 25/36 | (2006.01) |
| (11) | Number of the document | 1694363 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04814802.7 |
| Date of filing the European patent application | 2004-12-16 | |
| (97) | Date of publication of the European application | 2006-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-22 |
| (46) | Date of publication of the claims translation | 2014-06-25 |
| (86) | Number | PCT/US2004/042661 |
| Date | 2004-12-16 |
| (87) | Number | WO 2005/058367 |
| Date | 2005-06-30 |
| (30) | Number | Date | Country code |
| 530122 P | 2003-12-16 | US |
| (72) |
BENTLEY, Michael, D., US
VIEGAS, Tacey, X., US
GOODIN, Richard, R., US
CHENG, Lin, US
ZHAO, Xuan, US
|
| (73) |
Nektar Therapeutics,
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Monodispersinės pegiliuoto naloksolio kompozicijos |
| Monodisperse PEGylated naloxol compositions |
| Payment date | Validity (years) | Amount | |
| 2023-11-27 | 347.00 EUR |